Trial Profile
Double-blind, Randomized clinical study of GGS (Intravenous Immunoglobulin) in patients with CSS/AGA. Phase 3 study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Churg-Strauss syndrome
- Focus Registrational; Therapeutic Use
- Sponsors Teijin Pharma
- 20 May 2016 New trial record